CRNX
Crinetics Pharmaceuticals, Inc. · Healthcare
Chief Scientific Officer Stephen F. Betz sold $142K of Crinetics Pharmaceuticals, Inc.
Sold$142,470
$47.49Price
3,000Shares
−3%Stake
What CRNX did after the filing
- The stock from Thu, May 30 close, $45.37
- +19.3%
- S&P 500, same days
- +7.8%
Measured over 30 trading days, to the Jul 15 close.
Traded Tue, May 28. Filed Thu, May 30, 12:28 PM ET, during the session. Returns use the May 30 close and the Jul 15 close. Not investment advice.